Fattah Clinical Pharmacy 1

Embed Size (px)

Citation preview

  • 7/27/2019 Fattah Clinical Pharmacy 1

    1/92

    Clinical Pharmacy

  • 7/27/2019 Fattah Clinical Pharmacy 1

    2/92

    Dr Abdelfattah Marrie

    Professor of ClinicalPharmacology and Pharmacy

    Contacts

    [email protected]

  • 7/27/2019 Fattah Clinical Pharmacy 1

    3/92

    Module Specifications

  • 7/27/2019 Fattah Clinical Pharmacy 1

    4/92

    Introduction to Clinical

    Pharmacy

    A key role for

    pharmacists

  • 7/27/2019 Fattah Clinical Pharmacy 1

    5/92

    1-Preparing.2-Counting.

    3-Dispensing.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    6/92

  • 7/27/2019 Fattah Clinical Pharmacy 1

    7/92

    objectives

    1. Define clinical pharmacy.2. Differentiate between traditional

    pharmacists role and Clinical

    Pharmacist.3. Explain the qualification required

    for clinical pharmacists.

    . Describin! the communications"ills.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    8/92

    objectives#. $ist the clinical pharmacists

    responsibilities.%. Describe the daily wor" acti&ity of

    clinical pharmacists.

    '. (uidelines for Pharmacotherapy.). Principles of Clinical

    Pharmaco"inetics and

    Therapeutic Drug Monitoring(TDM).

    *. Problem +riented ,pproach.

    1-. Interpretation of laboratory testsresults.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    9/92

    Clinical Pharmacy

    Clinical pharmacy is defined

    as that area of pharmacyconcerned with the science

    and practice of rational

    medication use.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    10/92

    Clinical Pharmacy

    Clinical Pharmacy includes all the

    ser&icesperformed by pharmacists

    practisin! in hospitals/ community

    pharmacies/ nursin! homes/ home0

    based care ser&ices/ clinics and anyother settin! where medicines are

    prescribed and used.

    he term clinical does notnecessarily imply an acti&ity

    implemented in a hospital settin!.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    11/92

    4ow does clinical pharmacy

    differ from pharmacy5

    he discipline of pharmacyembraces the "nowled!e on6

    o7ynthesis/oChemistry andoPreparation of dru!s.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    12/92

    4ow does clinical pharmacy

    differ from pharmacy5

    Clinical pharmacy is moreoriented to the6o ,nalysis of population needs withre!ards to medicines/o Dosa!e and ways of administration/o Patterns of use and

    o Dru!s effects on the patients.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    13/92

    4ow does clinical pharmacy

    differ from pharmacy5

    he focus of attention mo&esfrom the dru! to the sin!le

    patient or population recei&in!dru!s.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    14/92

    (oal of Clinical Pharmacy

    o promote the correct andappropriate use of medicinal

    products and de&ices.

    hese acti&ities aim at68aximisin! the clinical effect of

    medicines.

    8inimisin! the ris" of treatment0induced ad&erse e&ents.

    8inimisin! the expenditures for

    pharmacolo!ical treatments.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    15/92

    Clinical Pharmacy Requirements

    no!ledge of

    nondrug therapy

    "herapeutic

    planning

    s#ills

    Drug $nformation

    S#ills

    Physical

    assessment

    s#ills

    Patient

    monitoring

    s#ills

    Communication

    s#ills

    no!ledge of

    la%oratory

    and diagnostic s#ills

    no!ledge of

    the disease

    no!ledge ofdrug therapy

    Patient care

  • 7/27/2019 Fattah Clinical Pharmacy 1

    16/92

    Communication S#ills in

    Clinical Pharmacy

  • 7/27/2019 Fattah Clinical Pharmacy 1

    17/92

    Communication in Clinical

    Pharmacy

    Communication is the

    dialogue & 'er%al( !ritten or

    others & %et!een thepharmacist and the patient

    and)or other health carepro'iders to insure optimal

    patient outcomes.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    18/92

    $mportance

    Proper communication*

    +etter patient compliance.

    ,ess patient complains.

    igh success rates of patient

    outcomes.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    19/92

    S#ills

    se the proper type of

    question.

    /mpathetic response.

    Responsi%le language use.

    0sserti'eness.

    Conflict management.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    20/92

    "ypes of uestions

    1. pen-ended questions gi'es the patient the

    chance to ans!er using his)her options*

    0. ery pen-ended4 sually starts !ith 56hat7

    +. Moderately open4 usually %egins !ith 56ho7(56hen7( 56here7 and 5o!7

    2. Restricted* "he patient ans!ers %y choosing

    form options gi'en %y the inquirer.3. ,eading questions* Phrasing the question in a

    !ay that it implies the ans!er.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    21/92

    0'oid

    uestions that imply criticism

    or accusing of the patient. "his

    !ill pro'o#e a defensi'ereaction from the patient and

    may gi'e improper ans!ers.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    22/92

    /mpathetic Response

    Specially in a deeply emotionalpatients*

    Patience( and gi'e the patientadequate time.Reflecti'e responding( that

    includes acti'e listening thatreflects the thought or feeling ofthe spea#er.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    23/92

    $e&el of ,ction of Clinical

    Pharmacists

    Clinical pharmacy acti&ities may

    influence the correct use of

    medicines at three different le&els6o 9efore/

    o Durin! and

    o ,fter the prescription is written.

  • 7/27/2019 Fattah Clinical Pharmacy 1

    24/92

    1. 9efore the prescription

    1.Clinical trials

    2.:ormularies

    3.Dru! information

    .Dru!0related policies

  • 7/27/2019 Fattah Clinical Pharmacy 1

    25/92

    2. Durin! the prescription

    1. Counsellin!acti&ity ;Physician Monitoring therapy(

  • 7/27/2019 Fattah Clinical Pharmacy 1

    92/92

    p g py

    patient education and e'aluation

    6hat criteria !ould you select to

    monitor Mr 8+ therapy and !hat

    information !ould you share !iththe patient B